ResearchMoz

China Pharmaceutical Equipment Industry Report, 2013 - 2016

Research In China
Published Date » 2014-02-13
No. Of Pages » 92
 After decades of development, China has become a major producer of pharmaceutical equipment in the world. Since 2010, affected by the new GMP certification and other factors, the revenue and total profit of China’s pharmaceutical equipment industry both have increased significantly, and the revenue achieved a year-on-year growth rate of 51.5%, 28.2% and 26% in 2010-2012 respectively. 
   
 However, restricted by the actual progress of new GMP certification and market capacity, the revenue growth of China’s pharmaceutical equipment industry will slow down in 2013-2016, probably at an annual average growth rate of 20% or so, and the revenue is expected to reach RMB 53.22 billion in 2016.  
   
 Due to a wide range of pharmaceutical equipment product categories and a...
Table of Content

1. Overview of Pharmaceutical Equipment Industry 
1.1 Definition
1.2 Classification

2. Overview of Chinese Pharmaceutical Equipment Industry 
2.1 Development Status
2.1.1 Sales
2.1.2 Profit 
2.1.3 Asset Utilization Efficiency
2.1.4 Export
2.1.5 Market Demand
2.2 Competition Pattern 
2.2.1 Industry Concentration 
2.2.2 Entry Barriers 
2.2.3 SWOT Analysis
2.3 Technology Status and Trends 
2.3.1 Technology Status and Features
2.3.2 Technology Trends

3. Development Environment of China Pharmaceutical Equipment Industry 
3.1 Policy Environment
3.1.1 Regulatory System
3.1.2 Industry Policy
3.2 Upstream and Downstream Industries
3.2.1 Industrial Chain
3.2.2 Upstream 
3.2.3 Downstream 

4. China Pharmaceutical Equipment Industry Development Forecast 
4.1 Overall Forecast
4.1.1 Industry Periodicity 
4.1.2 Market Scale 
4.2 Market Segments 
4.2.1 Sterilization Equipment Market Status and Scale Forecast
4.2.2 Drying Equipment Market Status and Scale Forecast
4.2.3 Injection Packaging Market Status and Scale Forecast
4.3 Development Trends of Pharmaceutical Equipment Industry
4.3.1 Leading Enterprises Develop Rapidly Through Mergers and Acquisitions
4.3.2 Product Line Seeks Systematic Development
4.3.3 Import Substitution Starts in High-end Market 

5. Major Enterprises of China Pharmaceutical Equipment Industry
5.1 Shinva Medical Instrument Co., Ltd.
5.1.1 Profile
5.1.2 Operation
5.1.3 Revenue Structure
5.1.4 Gross Margin
5.1.5 Investment
5.1.6 Pharmaceutical Equipment Business
5.1.7 Forecast and Outlook
5.2 Shanghai Tofflon Science and Technology Co., Ltd.
5.2.1 Profile
5.2.2 Operation
5.2.3 Revenue Structure
5.2.4 Gross Margin
5.2.5 Clients and Suppliers
5.2.6 R&D and Investment
5.2.7 Forecast and Outlook
5.3 Hunan China Sun Pharmaceutical Machinery Co., Ltd. 
5.3.1 Profile
5.3.2 Operation
5.3.3 Revenue Structure
5.3.4 Gross Margin
5.3.5 Clients and Suppliers
5.3.6 R&D and Investment
5.3.7 Forecast and Outlook
5.4 Truking Technology Limited 
5.4.1 Profile
5.4.2 Operation
5.4.3 Revenue Structure
5.4.4 Gross Margin
5.4.5 Clients and Suppliers
5.4.6 R&D and Investment
5.4.7 Forecast and Outlook
5.5 Beijing Double-Crane Pharmaceutical Equipment Co., Ltd.
5.5.1 Profile
5.5.2 Operation
5.6 Harbin Nano Pharmaceutical & Chemical Equipment Co., Ltd.
5.6.1 Profile
5.6.2 Operation
5.7 Shanghai Far-East Pharmaceutical Machinery Co., Ltd.
5.7.1 Profile
5.7.2 Operation
5.8 Wenzhou Yaguang Machinery Manufacturing Co., Ltd. 
5.8.1 Profile
5.8.2 Operation
5.9 Jiangsu Saideli Pharmaceutical Machine Co., Ltd.
5.9.1 Profile
5.9.2 Operation
5.10 Zhejiang Hualian Pharmaceutical Machinery Co., Ltd.
5.10.1 Profile
5.10.2 Operation

List of Tables


List of Figures

Upcoming Reports:

Clear Brine Fluids Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019
By - Transparency Market Research
Clear brine fluid is a solution used for servicing wells in the oil and gas sector. They are preferred over drilling muds due to being relatively cheaper and effective. Clear brine fluids find applications in deep, high-pressure oil wells where conventional drilling muds can block the formations. In addition, they are also used in oil sands and deep water wells. The market for clear brine fluids is divided into two types, viz. single salt and multi salt fluids. The market for clear brine fluids was mainly driven by drilling fluids market. Clear brine fluids are used to facilitate oil and...
Carbon Dioxide (CO2) Monitors Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2019
By - Transparency Market Research
Carbon Dioxide (CO2) monitors measures partial pressure or gas concentration with the use of two configurations namely, sidestream and mainstream. Mainstream CO2 monitors measure the respiratory gas directly from airway. Whereas, sidestream devices measure the respiratory gas through nasal or oral cannula. The global carbon dioxide monitors market is witnessing a significant growth owing to increasing requirements in patient monitoring and emerging new application areas. Capnography, recovery rooms, emergency rooms, post anesthesia care units, critical care units and others are various...
Acetylene Gas Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2014 - 2020
By - Transparency Market Research
Acetylene gas is a highly flammable colorless gas with a triple bond structure. Acetylene gas possesses garlic like odor and has a high flame temperature. The gas is produced by reaction of calcium carbide and water. The reaction produces acetylene gas and calcium carbonate slurry or hydrated lime as a byproduct. Acetylene gas is also produced from hydrocarbon sources such as naphtha, crude oil and coal among others. Several other gases such as carbon dioxide, hydrogen and carbon monoxide among others are also produces as byproducts in the process. Solvents such as water, chilled methanol,...

Research Assistance

We will be happy to help you find what you need.
Please call us or write us:

866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-618-1030
Email: sales@researchmoz.us
Select License type:

Share this report

Related News

Order cancellations not a sign of market slump: Airbus
Jul 31, 2014  
Leading aircraft manufacturer Airbus on Wednesday said that the recent wave of order cancellations for its commercial jetliners do not mean that the market has declined. The market is still strong and single-aisle jets deals are likely to return later. A total of 225 Airbus cancellations were reported since the beginning of this year. Of these, Dubai’s Emirates Airlines alone...
Leading Australian Universities Want to Hike Fees, Enroll Fewer Students
Jul 31, 2014  
Australia’s prestigious group of top eight universities, also known as the Group of Eight (Go8), has indicated plans of increasing tuition fees while reducing the number of students they enroll, a reform-backer has predicted. These decisions could be made if the universities are deregulated .  Arguing for this decision, the chairman of Go8, and vice chancellor of the ANU, Ian...
Bristol-Myers Squibb Posts USD 3.9 billion Revenues in 2014 Second Quarter
Jul 30, 2014  
Leading bio-pharmaceutical company Bristol-Myers Squibb has registered revenues of USD 3.9 billion in the 2014 second quarter. This marks a 4% decrease from the same period in 2013. The global revenues of the company (excluding the divested Diabetes Alliance), saw a 7% increase. In this quarter, the company’s results were underlined by steady global sales of nearly each of its...
Novartiss Simbrinza gets approval from the EU
Jul 30, 2014  
Glaucoma patients in Europe can easily obtain Novartis’ Simbrinza eye drops which are a combination of brimonidine tartrate and brinzolamide and it is without a beta-blocker. This eye drop has got the approval of the European Commission. Unlike the inefficient treatment provided by monotherapy, this eye drop aims at treating intraocular pressure or IOP in adults with ocular hypertension...
Second Treaty Between Zealand And Boehringer Ingelheim
Jul 30, 2014  
Denmark based Pharma group Zealand Pharma and Germany’s Boehringer Ingelheim have signed an accord to formulate new medicines for advanced and effective treatment of cardio-metabolic maladies. The collaboration between these two Pharma groups involves a new therapeutic peptide project from the list of preclinical programs of Zealand Pharma.  Both these companies are aiming...